Before 2021 reaches its end, Pfizer may release a pill that can treat early-stage COVID-19 infections at home, according to the company’s CEO. The drug will be designed to inhibit the enzyme SARS-CoV-2 needs to infiltrate human cells, though its eventual potential distribution in the US will depend on clinical trials and the FDA. Pfizer was the first to get …
Before 2021 reaches its end, Pfizer may release a pill that can treat early-stage COVID-19 infections at home, according to the company’s CEO. The drug will be designed to inhibit the enzyme SARS-CoV-2 needs to infiltrate human cells, though its eventual potential distribution in the US will depend on clinical trials and the FDA. Pfizer was the first to get …
Share this Article
Recommended